Learn more Got it! Contact Us CORPORATE HEAD OFFICE Zymeworks Inc 1385 West 8th Avenue, Suite 540 Vancouver BC, Canada V6H 3V9 T. (604) 678-1388 F. (604) 737-7077 Zymeworks Vancouver U.S. BIOTHERAPEUTICS R&D SITE Zymeworks Biopharmaceuticals Inc 1215 4th Avenue, Suite 2100 Seattle WA, 98161 T. (206) 237-1030 Zymeworks Seattle FULL NAME * COMPANY EMAIL * PHONE NATURE OF INQUIRY * General Investor Relations Partnering & BD HR Media MESSAGE * SEND MESSAGE TECHNOLOGY Azymetric™ ZymeLink™ EFECT™ ProTECT™ Science PIPELINE Zanidatamab ZW49 Preclinical Candidates Partnerships Publications For Patients INVESTORS Stock Info News Releases Events & Presentations Financials Governance CORPORATE Leadership Board of Directors Careers Legal Privacy Contact Twitter LinkedIn

Zanidatamab: WATCH ZANIDATAMAB IN ACTION Click on a dot to see more information FAB scFV Fc Patients Pipeline Partners Technology Careers About Investors & Media Privacy Policy Contact Us Zanidatamab is an investigational product and has not been demonstrated to be safe and effective. © Copyright 2021 - Zymeworks